Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

ABSTRACT: PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

PROVIDER: PRJNA846482 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

Project description:PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

| PRJNA846483 | ENA

RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI

Project description:Not all prostate cancers are visible on multiparametric MRI. The biologic basis and clinical implication of MRI visibility are unknown. We sought to identify genes associated with prognosis and MRI visibility.

2018-02-22 | GSE95369 | GEO

MRI-lytic-lesion

Project description:This series represents samples of multiple myeloma patients with bone lytic lesion by MRI. Keywords = multiple myeloma Keywords = osteolytic lesions Keywords = MRI Keywords = osteoblast Keywords = mesenchymal stem cell Keywords = Wnt signaling Keywords = DKK1 Keywords: other

2004-01-01 | GSE754 | GEO

NHLBI TOPMed: REDS-III Brazil SCD Cohort

Project description:NHLBI TOPMed: REDS-III Brazil SCD Cohort

| PRJNA413278 | ENA

NHLBI TOPMed: REDS-III Brazil SCD Cohort

Project description:NHLBI TOPMed: REDS-III Brazil SCD Cohort

| PRJNA413277 | ENA

MRI-no-lytic-lesion

Project description:This series represents samples of multiple myeloma patients without bone lytic lesion by MRI. Keywords = multiple myeloma Keywords = osteolytic lesions Keywords = MRI Keywords = osteoblast Keywords = mesenchymal stem cell Keywords = Wnt signaling Keywords = DKK1 Keywords: other

2004-01-01 | GSE753 | GEO

NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)

Project description:NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)

| PRJNA472123 | ENA

NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)

Project description:NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)

| PRJNA472122 | ENA

MRI lytic and no lytic lesions

Project description:This series represents samples of multiple myeloma patients with and without bone lytic lesion by MRI. Keywords = multiple myeloma Keywords = osteolytic lesions Keywords = MRI Keywords = osteoblast Keywords = mesenchymal stem cell Keywords = Wnt signaling Keywords = DKK1 Keywords: other

2004-01-01 | GSE755 | GEO

Effects of labelling fetal MSC with MRI Particles: MGIO and Ferucarbotran

Project description:Cell tracking is enabled by incubating ex vivo cells with commercially/clinically available MRI particulate label, such as ferucarbotran. However, the uptake by non-phagocytic cells, such as mesenchymal stem cell (MSC) is poor, and the detection by MRI is impeded. MGIO is a new label that is efficiently taken up by MSC. The proliferation and differentiation capacity of labelled cells are usually assessed to determine cytotoxicity. In this study, we compared the global gene expression profiles of mock-labelled, ferucarbotran-labelled and MGIO-labelled fetal MSC.

2009-02-01 | GSE13975 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data